Literature DB >> 35482294

Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation.

Masahiko Nishitani-Isa1, Kojiro Mukai2, Yoshitaka Honda1,3,4, Hiroshi Nihira1, Takayuki Tanaka1, Hirofumi Shibata1, Kumi Kodama1, Eitaro Hiejima1, Kazushi Izawa1, Yuri Kawasaki5, Mitsujiro Osawa5, Yu Katata6, Sachiko Onodera6, Tatsuya Watanabe6, Takashi Uchida7, Shigeo Kure7, Junko Takita1, Osamu Ohara8, Megumu K Saito5, Ryuta Nishikomori9, Tomohiko Taguchi2, Yoji Sasahara7, Takahiro Yasumi1.   

Abstract

Mutations in the C-terminal region of the CDC42 gene cause severe neonatal-onset autoinflammation. Effectiveness of IL-1β-blocking therapy indicates that the pathology involves abnormal inflammasome activation; however, the mechanism underlying autoinflammation remains to be elucidated. Using induced-pluripotent stem cells established from patients carrying CDC42R186C, we found that patient-derived cells secreted larger amounts of IL-1β in response to pyrin-activating stimuli. Aberrant palmitoylation and localization of CDC42R186C protein to the Golgi apparatus promoted pyrin inflammasome assembly downstream of pyrin dephosphorylation. Aberrant subcellular localization was the common pathological feature shared by CDC42 C-terminal variants with inflammatory phenotypes, including CDC42*192C*24 that also localizes to the Golgi apparatus. Furthermore, the level of pyrin inflammasome overactivation paralleled that of mutant protein accumulation in the Golgi apparatus, but not that of the mutant GTPase activity. These results reveal an unexpected association between CDC42 subcellular localization and pyrin inflammasome activation that could pave the way for elucidating the mechanism of pyrin inflammasome formation.
© 2022 Nishitani-Isa et al.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35482294      PMCID: PMC9059393          DOI: 10.1084/jem.20211889

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   17.579


  46 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.

Authors:  J P Moorman; D Luu; J Wickham; D A Bobak; C S Hahn
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

3.  Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes.

Authors:  Simone Martinelli; Oliver H F Krumbach; Francesca Pantaleoni; Simona Coppola; Ehsan Amin; Luca Pannone; Kazem Nouri; Luciapia Farina; Radovan Dvorsky; Francesca Lepri; Marcel Buchholzer; Raphael Konopatzki; Laurence Walsh; Katelyn Payne; Mary Ella Pierpont; Samantha Schrier Vergano; Katherine G Langley; Douglas Larsen; Kelly D Farwell; Sha Tang; Cameron Mroske; Ivan Gallotta; Elia Di Schiavi; Matteo Della Monica; Licia Lugli; Cesare Rossi; Marco Seri; Guido Cocchi; Lindsay Henderson; Berivan Baskin; Mariëlle Alders; Roberto Mendoza-Londono; Lucie Dupuis; Deborah A Nickerson; Jessica X Chong; Naomi Meeks; Kathleen Brown; Tahnee Causey; Megan T Cho; Stephanie Demuth; Maria Cristina Digilio; Bruce D Gelb; Michael J Bamshad; Martin Zenker; Mohammad Reza Ahmadian; Raoul C Hennekam; Marco Tartaglia; Ghayda M Mirzaa
Journal:  Am J Hum Genet       Date:  2018-01-25       Impact factor: 11.025

4.  A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome.

Authors:  Bahia Bekhouche; Aurore Tourville; Yamini Ravichandran; Rachida Tacine; Laurence Abrami; Michael Dussiot; Andrea Khau-Dancasius; Olivia Boccara; Meriem Khirat; Marianne Mangeney; Florent Dingli; Damarys Loew; Batiste Boëda; Pénélope Jordan; Thierry Jo Molina; Nathalia Bellon; Sylvie Fraitag; Smail Hadj-Rabia; Stéphane Blanche; Anne Puel; Sandrine Etienne-Manneville; F Gisou van der Goot; Jacqueline Cherfils; Olivier Hermine; Jean-Laurent Casanova; Christine Bodemer; Asma Smahi; Jérôme Delon
Journal:  J Allergy Clin Immunol       Date:  2020-04-10       Impact factor: 10.793

5.  Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.

Authors:  Hirofumi Shibata; Takahiro Yasumi; Saeko Shimodera; Eitaro Hiejima; Kazushi Izawa; Tomoki Kawai; Ryutaro Shirakawa; Taizo Wada; Ryuta Nishikomori; Hisanori Horiuchi; Osamu Ohara; Eiichi Ishii; Toshio Heike
Journal:  Blood       Date:  2018-03-16       Impact factor: 22.113

6.  A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells.

Authors:  Masato Nakagawa; Yukimasa Taniguchi; Sho Senda; Nanako Takizawa; Tomoko Ichisaka; Kanako Asano; Asuka Morizane; Daisuke Doi; Jun Takahashi; Masatoshi Nishizawa; Yoshinori Yoshida; Taro Toyoda; Kenji Osafune; Kiyotoshi Sekiguchi; Shinya Yamanaka
Journal:  Sci Rep       Date:  2014-01-08       Impact factor: 4.379

7.  A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function.

Authors:  Michael T Lam; Simona Coppola; Oliver H F Krumbach; Giusi Prencipe; Antonella Insalaco; Mohammad R Ahmadian; Jordan S Orange; Fabrizio De Benedetti; Marco Tartaglia; Cristina Cifaldi; Immacolata Brigida; Erika Zara; Serena Scala; Silvia Di Cesare; Simone Martinelli; Martina Di Rocco; Antonia Pascarella; Marcello Niceta; Francesca Pantaleoni; Andrea Ciolfi; Petra Netter; Alexandre F Carisey; Michael Diehl; Mohammad Akbarzadeh; Francesca Conti; Pietro Merli; Anna Pastore; Stefano Levi Mortera; Serena Camerini; Luciapia Farina; Marcel Buchholzer; Luca Pannone; Tram N Cao; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Luca Basso-Ricci; Maria Chiriaco; Radovan Dvorsky; Lorenza Putignani; Rita Carsetti; Petra Janning; Asbjorg Stray-Pedersen; Hans Christian Erichsen; AnnaCarin Horne; Yenan T Bryceson; Lamberto Torralba-Raga; Kim Ramme; Vittorio Rosti; Claudia Bracaglia; Virginia Messia; Paolo Palma; Andrea Finocchi; Franco Locatelli; Ivan K Chinn; James R Lupski; Emily M Mace; Caterina Cancrini; Alessandro Aiuti
Journal:  J Exp Med       Date:  2019-10-10       Impact factor: 14.307

8.  Homeostatic regulation of STING by retrograde membrane traffic to the ER.

Authors:  Kojiro Mukai; Emari Ogawa; Rei Uematsu; Yoshihiko Kuchitsu; Fumika Kiku; Takefumi Uemura; Satoshi Waguri; Takehiro Suzuki; Naoshi Dohmae; Hiroyuki Arai; Anthony K Shum; Tomohiko Taguchi
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

9.  Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.

Authors:  Hanne Van Gorp; Pedro H V Saavedra; Nathalia M de Vasconcelos; Nina Van Opdenbosch; Lieselotte Vande Walle; Magdalena Matusiak; Giusi Prencipe; Antonella Insalaco; Filip Van Hauwermeiren; Dieter Demon; Delfien J Bogaert; Melissa Dullaers; Elfride De Baere; Tino Hochepied; Joke Dehoorne; Karim Y Vermaelen; Filomeen Haerynck; Fabrizio De Benedetti; Mohamed Lamkanfi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-22       Impact factor: 11.205

10.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

View more
  2 in total

Review 1.  Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.

Authors:  Takayuki Tanaka; Takeshi Shiba; Yoshitaka Honda; Kazushi Izawa; Takahiro Yasumi; Megumu K Saito; Ryuta Nishikomori
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 2.  Immune-mediated inflammatory diseases with chronic excess of serum interleukin-18.

Authors:  Hanae Miyazawa; Taizo Wada
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.